NMR Spectroscopy of Biofluids

Metabonomics in Toxicity Assessment

Volumn , Issue , 2005, Pages 105-172

  Lindon, John C ^a   Nicholson, Jeremy K ^a   Holmes, Elaine ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547111855     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14117-7     Document Type: Chapter

References (131)

1. Nicholson JK, Wilson ID. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog NMR Spectrosc 1989; 21: 444-501.
2. Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn Reson 2000; 12: 289-320.
3. 13C NMR spectroscopy of human blood plasma. Anal Chem 1995; 67: 793-811.
4. Wolters AM, Jayawickrama DA, Sweedler JV. Microscale NMR. Curr Opin Chem Biol 2002; 6: 711-716.
5. 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem 2002; 74: 4588-4593.
6. n groups using a heteronuclear multiple quantum filter and pulsed field gradients. J Magn Reson 1995; 106B: 270-278.
7. n groups using two-dimensional maximum quantum correlation spectroscopy. J Magn Reson 1995; A113: 208-219.
8. Willker W, Leibfritz D. Assignment of mono-and polyunsaturated fatty acids in lipids of tissues and body fluids. Magn Reson Chem 1998; 36: S79-S84.
9. Willker W, Flogel U, Leibfritz D. Ultra-high-resolved HSQC spectra of multiple-C-13-labeled biofluids. J Magn Reson 1997; 125: 216-219.
10. Spraul M, Niedig P, Klauck U, Kessler P, Holmes E, Nicholson JK, Sweatman BC, Salman SR, Farrant RD, Rahr E, Beddell CR, Lindon JC. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. J Pharm Biomed Anal 1994; 12: 1215-1225.
11. 1H NMR spectroscopy studies of blood plasma and other biofluids. NMR Biomed 1994; 7: 243-247.
12. Gibbs SJ, Johnson CS Jr. A PFG NMR experiment for accurate diffusion and flow studies in the presence of eddy currents. J Magn Reson 1991; 93: 395-402.
13. 1H diffusion-edited total correlation NMR spectroscopy (DETOCSY). Anal Chem 1997; 69: 1504-1509.
14. 1H NMR spectroscopy of biological fluids. Anal Chem 1996; 68: 3370-3376.
15. Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. In: Webb G.A., ed. Ann Rep NMR Spectrosc 1999; 38: 1-88.
16. Fan TW-M. Metabolite profiling by one-and two-dimensional NMR analysis of complex mixtures. Prog NMR Spectrosc 1996; 28: 161-219.
17. Petroff OAC, Yu RK, Ogino T. High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J Neurochem 1986; 47: 1270-1276.
18. Bell JD, Brown JCC, Sadler PJ, Macleod AF, Sönksen PH, Hughes RD, Williams R. High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. Clin Sci 1987; 72: 563-570.
19. 1H NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal 1993; 11: 651-664.
20. 1H NMR of cerebrospinal fluid. Clin Chem 1995; 41: 744-751.
21. Koschorek F, Gremmel H, Stelten J, Offermann W, Liebfritz D. Cerebrospinal fluid-detection of tumors and disk herniations with MR spectroscopy. Radiology 1988; 167: 813-816.
22. Koschorek F, Offermann W, Stelten J, Braunsdorf WE, Steller U, Gremmel H, Leibfritz D. High resolution H-1 NMR spectroscopy of cerebrospinal fluid in spinal diseases. Neurosurg Rev 1993; 16: 307-315.
23. Nicoli F, Vion-Dury J, Maloteaux JM, Delwaide C, Confort-Gouny S, Sciaky M, Cozzone PJ. CSF and serum metabolic profile of patients with Huntingtons-chorea-a study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 1993; 154: 47-51.
24. Bell JD, Brown JCC, Kubal G, Sadler PJ. NMR-invisible lactate in blood plasma. FEBS Lett 1988; 235: 81-86.
25. Commodari F, Arnold DL, Sanctuary BC, Shoubridge E. H-1 NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin-B12 deficient patient. NMR Biomed 1991; 4: 192-200.
26. 1H NMR study of rat cerebrospinal fluid composition: effects of photothrombotically induced experimental stroke. J Magn Reson Anal 1995; 1: 13-19.
27. Nicoli F, Vion-Dury J, Confort-Gouny S, Maillet S, Gastaut JL, Cozzone PJ. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. Comptes Rendus Serie III-Science de la Vie 1996; 319: 623-631.
28. Simone IL, Federico F, Trojano M, Tortorella C, Liguori M, Giannini P, Picciola E, Natile G, Livrea P. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. J Neurol Sci 1996; 144: 182-190.
29. Lynch J, Peeling J, Auty A, Sutherland GR. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis. Can J Neurol Sci 1993; 20: 194-198.
30. Ghauri FYK, Nicholson JK, Sweatman BC, Beddell CR, Lindon JC. NMR spectroscopy of human post mortem CSF: distinction of Alzheimer’s disease from controls using pattern recognition and statistics. NMR Biomed 1993; 6: 163-167.
31. 1H NMR spectroscopy. J Magn Reson Anal 1996; 2: 66-74.
32. Kriat M, Confort-Gouny S, Vion-Dury J, Sciaky M, Viout P, Cozzone PJ. Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy-a comparative study of the use of formate and TSP as concentration standards. NMR Biomed 1992; 5: 179-184.
33. Grootveld M, Claxson AWD, Chander CL, Haycock P, Blake DR, Hawkes GE. High resolution proton NMR investigations of rat blood plasma-assignment of resonances for the molecularly mobile carbohydrate side chains of acute-phase glycoproteins. FEBS Lett 1993; 322: 266-276.
34. Bell JD, Sadler PJ, Macleod AF, Turner PR, La Ville A. H-1 NMR studies of human blood plasma assignment of resonances for lipoproteins. FEBS Lett 1987; 219: 239-243.
35. Foxall PJD, Parkinson JA, Sadler IH, Lindon JC, Nicholson JK. Analysis of biological fluids using 600MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. J Pharm Biomed Anal 1993; 11: 21-31.
36. 1H NMR spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 2004; 325: 260-272.
37. 1H NMR spectroscopy of human blood plasma. Prog NMR Spectrosc 1995; 27: 475-554.
38. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992; 38: 1632-1638.
39. Bradamante S, Barchiesi E, Barenghi L, Zoppi F. Nn alternative expeditious analysis of phospholipid composition in human blood plasma by P-31 NMR spectroscopy. Anal Biochem 1990; 185: 299-303.
40. 1H NMRdetermined diffusion coefficients to characterize lipoprotein fractions in human blood plasma. Magn Reson Chem 2002; 40: S83-S88.
41. Hiltunen Y, Heiniemi E, Ala-Korpela M. Lipoprotein lipid quantification by neural network analysis of H-1 NMR data from human blood plasma. J Magn Reson 1995; B106: 191-194.
42. Bell JD, Brown JCC, Kubal G, Sadler PJ. NMR-invisible lactate in blood plasma. FEBS Lett 1988; 235: 81-86.
43. 1H NMR spectroscopy. J Pharm Biomed Anal 1993; 11: 897-902.
44. Fossel ET, Carr JM, McDonagh J. Detection of malignant-water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 1986; 315: 1369-1376.
45. Engan T, Krane J, Kvinnsland S. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma-significant variations with extent of breast cancer, duration of pregnancy and aging. NMR Biomed 1991; 4: 142-149.
46. Engan T, Krane J, Klepp O, Kvinnsland S. Proton nuclearmagnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. N Engl J Med 1990; 322: 949-958.
47. Hiltunen Y, Ala-Korpela M, Jokisaari J, Eskelinen S, Kiviniitty K. Proton nuclear magnetic resonance lineshape studies on human blood plasma lipids from newborn infants, healthy adults and adults with tumors. Magn Reson Med 1992; 26: 89-99.
48. Herring FG, Phillips PS, Pritchard H, Silver H, Whittal KP. The proton NMR of blood plasma and the test for cancer. Magn Reson Med 1990; 16: 35-48.
49. Vion-Dury J, Favre R, Sciaky M, Kriat M, Confort-Gouny S, Harle JR, Gazziani N, Viout P, Grisoli F, Cozzone PJ. Graphic-aided study of metabolic modifications of plasma in cancer using proton magnetic resonance spectroscopy. NMR Biomed 1993; 6: 58-65.
50. Höfeler H, Scheulen ME. Monitoring of patients with nonseminomatous testicular cancer by nuclear magnetic resonance spectroscopy of plasma. Eur J Cancer Clin On 1989; 25: 1141-1143.
51. Kriat M, Vion-Dury J, Rafre R, Maraninchi D, Harle JR, Confort-Gouny S, Sciaky M, Fontanarava E, Viout P, Cozzone PJ. Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone-marrow transplantation-a proton NMR spectroscopy study. Biochimie 1991; 73: 99-104.
52. 1H NMR relaxometry or high-resolution spectroscopy of plasma as a screening test for malignant lung disease. Magn Reson Med 1990; 13: 103-132.
53. Mountford CE, Lean CL, Mackinnon WB. The use of proton MR in cancer pathology. Ann Rep NMR Spectrosc 1993; 27: 173-215.
54. Eugene M, Le Moyec L, de Certaines JD, Desruennes M, Le Rumeur E, Fraysse JB, Cabrol C. Lipoproteins in heart transplantation: proton magnetic resonance spectroscopy of plasma. Magn Reson Med 1991; 18: 93-101.
55. Pont H, Vion-Dury J, Kriat M, Mouly-Bandini A, Sciaky M, Viout P, Confort-Gouny S, Messana T, Goudart M, Monties JR, Cozzone PJ. NMR spectroscopy of plasma during acute rejection of transplanted hearts. Lancet 1991; 337: 792-793.
56. Nishina M, Hori E, Matsushita K, Takahashi M, Ohsaka A. H-1 NMR spectroscopic study of serums from patients with malaria. Physiol Chem Phys Med NMR 1988; 20: 269-271.
57. Bell JD, Brown JCC, Sadler PJ. NMR studies of body fluids. NMR Biomed 1989; 2: 246-255.
58. Grasdalen H, Belton PS, Pryor JS, Rich GT. Quantitative proton magnetic resonance of plasma from uremic patients during dialysis. Magn Reson Chem 1987; 25: 811-816.
59. Holmes E, Foxall PJD, Nicholson JK. Proton NMR analysis of plasma from renal failure patients-evaluation of sample preparation and spectral editing methods. J Pharm Biomed Anal 1990; 8: 955-958.
60. Bell JD, Lee JA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure-identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991; 1096: 101-107.
61. 1H NMR spectroscopy of human blood plasma. J Pharm Biomed Anal 1993; 11: 267-276.
62. 1H spin echo NMR. FEBS Lett 1977; 82: 12-16.
63. Simpson RJ, Brindle KM, Brown FF, Campbell ID, Foxall DL. Studies of pyruvate-water isotope exchange catalyzed by erythrocytes and proteins. Biochem J 1981; 193: 401-406.
64. York MJ, Kuchel PW, Chapman BE, Jones AJ. Incorporation of labeled glycine into reduced glutathione of intact human erythrocytes by enzyme-catalyzed exchange-a NMR study. Biochem J 1982; 207: 65-72.
65. Rabenstein DL, Isab AA. Determination of the intracellular pH of intact erythrocytes by H-1 NMR spectroscopy. Anal Biochem 1982; 121: 423-432.
66. Brindle KM, Brown FF, Campbell ID, Grathwol C, Kuchel PW. Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport. Biochem J 1979; 180: 37-44.
67. King GF, York MJ, Chapman BE, Kuchel PW. Proton NMR spectroscopic studies of dipeptidase in human erythrocytes. Biochem Biophys Res Commun 1983; 110: 305-312.
68. Kuchel PW, Hunt GE, Johnson GFS, Beilharz GR, Chapman BE, Jones AJ, Singh BS. Renal function and lithium treatment-initial and follow-up tests in manic-depressive patients. J Affect Disord 1984; 6: 249-263.
69. 1H NMR methods for the noninvasive study of metabolism and other processes involving small molecules in intact erythrocytes. J Biochem Biophys Methods 1984; 9: 277-306.
70. Lennon AJ, Scott NR, Chapman BE, Kuchel PW. Hemoglobin affinity for 2, 3-bisphosphoglycerate in solutions and intact erythrocytes-studies using pulsed-field gradient nuclear magnetic resonance and monte-carlo simulations. Biophys J 1994; 67: 2096-2109.
71. Kuchel PW, Coy A, Stilbs P. NMR '‘diffusion-diffraction’' of water revealing alignment of erythrocytes in a magnetic field and their dimensions and membrane transport characteristics. Magn Reson Med 1997; 37: 637-643.
72. Torres AM, Michniewicz RJ, Chapman BE, Young GAR, Kuchel PW. Characterisation of erythrocyte shapes and sizes by NMR diffusion-diffraction of water: correlations with electron micrographs. Magn Reson Imaging 1998; 16: 423-434.
73. 1H MAS NMR spectroscopy. Magn Reson Med 1997; 38: 334-336.
74. 1H MAS NMR spectra of cell suspensions. Magn Reson Med 2003; 50: 515-521.
75. Connor S, Everett J, Nicholson J. Spin-echo proton NMR spectroscopy of urine samples-water suppression via a urea-dependent T2 relaxation process. Magn Reson Med 1987; 4: 461-470.
76. Foxall PJD, Kingdom JCP, Rodeck CH, Neild GH, Nicholson JK. The effect of gestational age on the urinary excretion of organic osmolytes. J Am Soc Nephrol 1995; 6: 361.
77. Davies SEC, Chalmers RA, Randall EW, Iles RA. Betaine metabolism in human neonates and developing rats. Clin Chim Acta 1988; 178: 241-250.
78. 1H NMR studies of urine during fasting: excretion of ketone bodies acetylcarnitine. Magn Reson Med 1986; 3: 849-856.
79. Griffin JL, Walker LA, Garrod S, Holmes E, Shore RF, Nicholson JK. NMR spectroscopy based metabonomic studies on the comparative biochemistry of the kidney and urine of the bank vole (Clethrionomys glareolus), wood mouse (Apodemus sylvaticus), white toothed shrew (Crocidura suaveolens) and the laboratory rat. Comp Biochem Physiol B-Biochem Mol Biol 2000; 127: 357-367.
80. Iles RA, Jago JR, Williams SR, Stacey TE, de Sousa C, Chalmers RA. Human carnitine metabolism studied by H-1 nuclear magnetic resonance spectroscopy. Biochem Soc Trans 1986; 14: 702-703.
81. Videen JS, Ross BD. Proton nuclear magnetic resonance urinalysis: coming of age. Kidney Int 1994; 46: S122-S128.
82. 1H NMR urinalysis. Clin Chim Acta 1993; 214: 165-173.
83. Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993; 43: 234-245.
84. Le Moyec L, Pruna A, Eugene M, Bedrossian J, Idatte JM, Huneau JF, Tomé D. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993; 65: 433-439.
85. Foxall PJD, Bending MR, Gartland KPR, Nicholson JK. Acute renal failure following accidental cutaneous absorption of phenol: application of NMR urinalysis to monitor the disease process. Human Toxicol 1989; 9: 491-496.
86. Vermeersch G, Marko J, Cartigny B, Leclerc F, Roussel P, Hermitte ML. Salicylate poisoning detected by H-1 NMR spectroscopy. Clin Chem 1988; 34: 1003-1004.
87. Malhotra D, Shapiro JI, Chan L. Nuclear magnetic resonance spectroscopy in patients with anion-gap acidosis. J Am Soc Nephrol 1991; 2: 1046-1050.
88. Pappas AA, Thompson JR, Fuller GL, Porter WH, Gadsen RH. High resolution proton nuclear magnetic resonance spectroscopy in the detection of low molecular weight volatiles. J Anal Toxicol 1993; 17: 273-277.
89. Bundy JG, Osborn D, Weeks JM, Lindon JC, Nicholson JK. An NMR-based metabonomic approach to the investigation of coelomic fluid biochemistry in earthworms under toxic stress. FEBS Lett 2001; 500: 31-35.
90. Gartland KPR, Beddell CR, Lindon JC, Nicholson JK. The application of pattern recognition methods to the analysis and classification of toxicological data derived from proton NMR spectroscopy of urine. Mol Pharmacol 1991; 39: 629-642.
91. Anthony ML, Sweatman BC, Beddell CR, Lindon JC, Nicholson JK. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol Pharmaco 1994; 46: 199-211.
92. Holmes E, Bonner FW, Sweatman BC, Lindon JC, Beddell CR, Rahr E, Nicholson JK. NMR spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression and recovery from nephrotoxic lesions in the rat induced by mercury(II)chloride and 2-bromo-ethanamine. Mol Pharmacol 1992; 42: 922-930.
93. 1H NMR spectra of urine using an artificial neural network. J Pharm Biomed Anal 1995; 13: 205-211.
94. Holmes E, Nicholson JK, Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol 2001; 14: 182-191.
95. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed 1998; 11: 235-244.
96. Holmes E, Nicholson JK, Nicholls AW, Lindon JC, Connor SC, Polley S, Connelly J. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemometrics Intell Lab Sys 1998; 44: 245-255.
97. Lynch MJ, Masters J, Pryor JP, Lindon JC, Spraul M, Foxall PJD, Nicholson JK. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J Pharm Biomed Anal 1994; 12: 5-19.
98. 1H NMR spectroscopic studies on dynamic biochemical processes in incubated human seminal fluid samples. Biochim Biophys Acta 1998; 1379: 367-380.
99. Kalic M, Kamp G, Lauterwein J. Nuclear magnetic resonance studies of boar seminal plasma. Problems encountered in the identification of small molecules: hypotaurine and carnitine. NMR Biomed 1997; 10: 341-347.
100. Segalen J, de Certaines JD, le Calve M, Colleu D, Bansard JY, Rio M. H-1 nuclear magnetic resonance of human seminal plasma in in-vitro fertilization attempts-use of automatic spectrum analysis. J Reprod Fertil 1995; 103: 181-187.
101. 1H nuclear magnetic resonance studies of seminal plasma from fertile infertile men. J Reprod Fertil 1993; 97: 51-55.
102. Sharma U, Chaudhury K, Jagannathan NR, Guha SK. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites. Reproduction 2001; 122: 431-436.
103. Levine AS, Foster N, Bean B. A comparison of human semen from healthy, sub-fertile and post-vasectomy donors by P-31 NMR spectroscopy. Ann NY Acad Sci 1987; 508: 466-468.
104. Hellou J, Banoub JH, Payne JF. C-13 NMR spectroscopy in the analysis of conjugate metabolites in the bile of fish exposed to petroleum. Chemosphere 1986; 15: 787-793.
105. 1H NMR studies that bile with shorter nucleation times contain cholesterol-enriched vesicles. Biochim Biophys Acta 1995; 1256: 360-366.
106. Degraaf MP, Groen AK, Bovee WMMJ. Determination of the distribution of lecithin (pl) and cholesterol (ch) between the micellar and vesicular phases in bile by H-1 and P-31 NMR. Gastroenterology 1993; 104: A894.
107. Nelson TR, Gillies RJ, Powell DA, Schrader MC, Manchester DK, Pretorius DH. High resolution proton NMR spectroscopy of human amniotic fluid. Prenatal Diagn 1987; 7: 363.
108. Bock JL. Metabolic profiling of amniotic fluid by proton nuclear magnetic resonance spectroscopy: correlation with fetal maturation and other clinical variables. Clin Chem 1994; 40: 56-61.
109. Lemoyec L, Muller F, Eugene M, Spraul M. Proton magnetic resonance spectroscopy of human amniotic fluids sampled at 17-18 weeks of pregnancy in cases of decreased digestive enzyme activities detected cystic fibrosis. Clin Biochem 1994; 27: 475-483.
110. 31P NMR. Magn Reson Med 1993; 29: 724-731.
111. Gosden RG, Sadler IH, Reed D, Hunter RHF. Characterization of ovarian follicular fluids of sheep, pigs and cows using proton nuclear magnetic resonance spectroscopy. Experientia 1990; 46: 1012-1015.
112. Eads TM, Bryant RG. High resolution proton NMR spectroscopy of milk, orange juice, and apple juice with efficient suppression of the water peak. J Agric Food Chem 1986; 34: 834-837.
113. Belton PS. Spectroscopic approaches to the measurement of food quality. Pure Appl Chem 1997; 69: 47-50.
114. 1H nuclear magnetic resonance investigation of synovial fluid components in osteoarthritis, and rheumatoid arthritis traumatic effusions. Br J Rheumatol 1989; 28: 23-27.
115. Grootveld MC, Herz H, Haywood R, Hawkes GE, Naughton D, Perera A, Knappitt J, Blake DR, Claxson AWD. Multicomponent analysis of radiolytic products in human body fluids using high field proton nuclear magnetic resonance (NMR) spectroscopy. Radiat Phys Chem 1994; 43: 445-453.
116. Herz H, Blake DR, Grootveld M. Multicomponent investigations of the hydrogen peroxide-and hydroxyl radical-scavenging antioxidant capacities of biofluids: the roles of endogenous pyruvate and lactate-relevance to inflammatory joint diseases. Free Radic Res 1997; 26: 19-35.
117. Grootveld M, Silwood CJL, Lynch EJ, Patel IY, Blake DR. The role of N-acetylcysteine in protecting synovial fluid biomolecules against radiolytically-mediated oxidative damage: A high field proton NMR study. Free Radic Res 1999; 30: 351-369.
118. 13C NMR investigation of synovial fluids. Magn Reson Med 1993; 30: 236-240.
119. 1H NMR spectroscopy. Exp Eye Res 1986; 42: 357-362.
120. Srivatsa GS, Chan MF, Chien DS, Tobias B. Detection and identification of endogenous small molecules in ocular tissues by proton nuclear magnetic resonance spectroscopy. Curr Eye Res 1991; 10: 127-132.
121. Greiner JV, Chanes LA, Glonek T. Comparison of phosphate metabolites of the ocular humors. Opthalmol Res 1991; 23: 92-97.
122. Harada H, Shimizu H, Maeiwa M. H-1 NMR of human saliva-an application of NMR spectroscopy in forensic science. Forensic Sci Int 1987; 34: 189-195.
123. Yamadanosaka A, Fukutomi S, Uemura S, Hashida T, Fujishita M, Kobayashi Y, Kyogoku Y. Preliminary nuclear magnetic resonance studies on human saliva. Arch Oral Biol 1991; 36: 697-701.
124. Silwood CJL, Lynch E, Claxson AWD, Grootveld MC. H-1 and C-13 NMR spectroscopic analysis of human saliva. J Dent Res 2002; 81: 422-427.
125. 2·). Free Radic Res 1997; 26: 209.
126. Powell JJ, Gartland KPR, Nicholson JK, Ainley CC, Thompson RPH. Bile, pancreatic-juice, and small-bowel secretions contain endogenous metal-binding ligands. Gut 1990; 31: A1197.
127. Foxall PJD, Price RG, Jones JK, Neild GH, Thompson FD, Nicholson JK. High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney-disease. Biochim Biophys Acta 1992; 1138: 305-314.
128. Coen M, Nicholson JK, Lindon JC, Lenz EM, Wilson ID, Ruepp SU, Pognan F. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J Pharm Biomed Anal 2004; 35: 93-105.
129. 2H-formate in urine as an indicator of bacterial contamination. J Pharm Biomed Anal 1993; 11: 169-172.
130. Nicholson JK, Buckingham MJ, Sadler PJ. High resolution H-1 NMR studies of vertebrate blood and plasma. Biochem J 1983; 211: 605-615.
131. Connor S, Nicholson JK, Everett JR. Chemical exchange and paramagnetic T2 relaxation agents for water suppression in spin-echo proton nuclear magnetic resonance spectroscopy of biological fluids. Anal Chem 1987; 59: 2885-2891.